跳至主要内容
临床试验/EUCTR2011-006276-40-ES
EUCTR2011-006276-40-ES进行中(未招募)不适用

Prevention of postoperative bleeding in bone tumors surgery: A multicenter, randomized, parallel controlled clinical trial evaluating the efficacy of topic fibrin glue, topic tranexamic acid and normal haemostasia in patients undergoing massive bone resection.

Institut de Recerca Hospital Sant Pau0 个研究点开始时间: 2012年2月28日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1) Patients over 18 years
  • 2) Bone tumor (primary or metastatic, benign or malignant) alocated in the extremities, or the pelvic or shoulder girdles.
  • 3) Massive or block resection of bone tumor.
  • 4) Signature of the patient's informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 115
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 15

排除标准

  • 1) Allergy to tranexamic acid or fibrin glue
  • 2) Background compatible with thromboembolic disease:
  • ? Ischemic heart disease
  • ? Deep vein thrombosis and / or superficial
  • ? Pulmonary thromboembolism
  • ? Peripheral arterial vascular disease
  • ? Iron therapy in post-operative period
  • ? Use of recuperatorsof blood during surgery
  • ? Patients with thrombogenic arrhythmias
  • ? Patients with prosthetic heart
  • ? Coagulation disorders prothrombotic
  • ? Treatment with contraceptive drugs

研究者

发起方
Institut de Recerca Hospital Sant Pau

相似试验